Patent Assignment
Reel/Frame 020119/0606
Assignment of Assignor's Interest
Recorded: 2007-11-16
Pages: 8
Assignor
AVENTIS PHARMACEUTICALS INC.
Executed: 2001-12-28
Assignee
HMR PHARMA INC.
10236 MARION PARK DRIVE, KANSAS CITY, MISSOURI, 10236
Covered Properties
(104)
Substituted Imidazo(2,1-B)Quinazolin-5(3H)-Ones and Related Tricyclic Compounds and Use as Bronchodilators
Patent:
4,871,732 →
Application:
07/247,797 →
1,4-Disubstituted-Piperidinyl Compounds Useful as Analgesis and Muscle Relaxants
Patent:
4,870,083 →
Application:
07/254,208 →
Use of 1,4-Disubstituted-Piperidinyl Compounds in the Manufacture of a Medicament for the Treatment of Insomnia
Patent:
4,908,369 →
Application:
07/299,913 →
5'-Deoxy-5',5'-Dihalo-Adenosines and Purine Analogues
Patent:
4,997,925 →
Application:
07/380,068 →
Medicament Compositions Derived from Quinolizine and Quinolizinone and Use Thereof
Patent:
5,011,846 →
Application:
07/527,676 →
Amino Acid Sequence for a Functional Human Interleukin-8 Receptor
Patent:
5,374,506 →
Application:
07/759,568 →
Novel Amino and Nitro Containing Tricyclic Compounds Useful as Inhibitors of Ace
Patent:
5,208,230 →
Application:
07/905,494 →
Sugar-Free Dry Mix Cellulose Ether Compositions as Bulk Laxatives
Patent:
5,266,334 →
Application:
07/922,130 →
Heteroarylpiperidines, Pyrrolidines and Piperazines and Their Use as Antipsychotics and Analetics
Patent:
5,364,866 →
Application:
07/969,383 →
Peptide Sequencing Using Mass Spectrometry
Patent:
5,470,753 →
Application:
08/068,947 →
Sulfonic Acid Derivatives in the Treatment of Viral Diseases
Patent:
5,359,131 →
Application:
08/106,311 →
Galanthamine Derivatives as Acetylcholinesterase Inhibitors
Patent:
6,323,195 →
Application:
08/137,440 →
Galanthamine Derivatives as Acetylcholinesterase Inhibitors
Patent:
6,323,196 →
Application:
08/137,443 →
Galanthamine Derivatives as Acetylcholinesterase Inhibitors
Patent:
6,316,439 →
Application:
08/137,444 →
Arylalkoxyphenoxy-Imidazoline Compounds
Patent:
5,407,954 →
Application:
08/194,137 →
Preparation of N-Alkyl-N-Pyridinyl-1H-Indol-1-Amines
Patent:
5,459,274 →
Application:
08/242,395 →
Topologically Segregated, Encoded Solid Phase Libraries
Patent:
5,840,485 →
Application:
08/249,830 →
Selectively Cleavable Linkers Based on Iminodiacetic Acid Esters for Solid Phase Peptide Synthesis
Patent:
5,635,598 →
Application:
08/263,289 →
Apparatus and Method for Random Polymer Synthesis
Patent:
5,651,943 →
Application:
08/273,090 →
Heteroarylpiperidines, Pyrrolidines and Piperazines and Their Use as Antipsychotics and Analgetics
Patent:
5,658,911 →
Application:
08/309,395 →
3-(Heteroaryl)-1-[(2,3-Dihydro-1H-Isoindol-2-Yl)Alkyl]Pyrrolidines and 3-(Heteroaryl)-1-[(2,3-Dihydro-1H-Indol-1-Yl)Alkyl]Pyrrolidines and Related Compounds and Their Therapeutic Utility
Patent:
5,776,963 →
Application:
08/329,000 →
Combinatorial Libraries Having a Predetermined Frequency of Each Species of Test Compound
Patent:
5,688,696 →
Application:
08/354,199 →
Method of Providing and Anthihistaminic Effect in a Hepatically Impaired Patient
Patent:
6,037,353 →
Application:
08/397,542 →
[1-Indanon-2-Yl]Methylpiperidines
Patent:
6,413,986 →
Application:
08/435,079 →
Preparation of N-Alkyl-N-Pyridinyl-1H-Indol-1-Amines
Patent:
5,644,062 →
Application:
08/455,468 →
Preparation of N-Alkyl-N-Pyridinyl-1H-Indol-1-Amines
Patent:
6,512,125 →
Application:
08/455,469 →
N-[4-Heteroaryl-1-Piperidinyl)Alkyl]Phthalimides and Related Compounds and Their Therapeutic Utility
Patent:
5,977,140 →
Application:
08/465,863 →
4-Heteroaryl-1-Piperazinealkylamines and Their Therapeutic Utility
Patent:
5,977,113 →
Application:
08/466,241 →
[(4-Heteroaryl-1-Piperazinyl)-Alkoxy]-3,4-Dihydor-1(2H)Naphthalenones and Related Compounds and Their Therapeutic Utility
Patent:
6,001,834 →
Application:
08/466,252 →
Heteroarylpiperidines, and Their Use as Antipsychotics and Analgesico
Patent:
5,607,945 →
Application:
08/466,821 →
1-(Arylthioalkyl, Arylaminoalkyl or Arylmethylenealkyl)-3-(Heteroaryl)Pyrrolidines and Related Compounds Useful as Antipsychotics and Analgesics
Patent:
5,889,035 →
Application:
08/467,133 →
3-Heteroaryl-1-Pyrrolidinealkylamines and Derivatives Thereof and Their Therapeutic Utility
Patent:
6,043,240 →
Application:
08/467,401 →
N-[(4-Heteroaryl-1-Piperazinyl)Alkyl]Phthalimides and Related Compounds and Their Therapeutic Utility
Patent:
5,998,417 →
Application:
08/468,065 →
4-Heteroaryl-1-Piperidinealkanols and Derivatives Thereof and Their Therapeutic Utility
Patent:
5,919,798 →
Application:
08/468,075 →
1-(Aryloxyalkyl)-4-(Heteroaryl)Piperidines and Related Compounds Useful as Antipsychotics and Analgesics
Patent:
6,140,345 →
Application:
08/468,611 →
2-[(4-Heteroaryl-1-Piperidinyl)Alkyl]-1,3-Dioxanes and Related Compounds and Their Therapeutic Utility
Patent:
5,811,435 →
Application:
08/468,991 →
1-(Aryloxyalkyl)-3- (Heteroaryl) Pyrrolidines and Related Compounds Useful as Antipsychotics and Analgesics
Patent:
5,614,543 →
Application:
08/469,000 →
Heteroarylpiperidines and Their Use as Antipsychotics and Anagesics
Patent:
5,591,745 →
Application:
08/469,365 →
Oral Pharmaceutical Composition of Piperidinoalkanol Compounds in Solution Form
Patent:
5,574,045 →
Application:
08/469,392 →
4-Heteroaryl-1-Piperazinealkanols and Derivatives Thereof and Their Therapeutic Utility
Patent:
5,874,435 →
Application:
08/470,039 →
Intermediate Compounds in the Synthesis of Heteroarylpiperidines, Pyrrolidines and Piperazines
Patent:
5,663,449 →
Application:
08/470,059 →
1-(Arylthioalkyl, Arylaminoalkyl or Arylmethylenealkyl)-4-(Heteroaryl) Piperidines and Related Compounds Useful as Antipsychotics and Analgesics
Patent:
6,110,938 →
Application:
08/471,032 →
Substituted 3-(Aminoalkylamino)-1,2-Benzisoxazoles and Related Compounds
Patent:
6,046,203 →
Application:
08/471,197 →
4-Heteroaryl-1-Piperazinealkylthiols and Derivatives Thereof and Their Therapeutic Utility
Patent:
5,889,004 →
Application:
08/471,393 →
1-[(2-Pyrimidinyloxy)Alkyl]4-(Heteroaryl)Piperazines and Related Compounds and Their Therapeutic Utility
Patent:
5,965,546 →
Application:
08/471,512 →
1[(2-Pyrimidinyloxy)Alkyl]-4-(Heteroaryl)Piperidines and Related Compounds and Their Therapeutic Utility
Patent:
5,811,430 →
Application:
08/471,754 →
Pharmaceutical Composition for Piperidinoalkanol Compounds
Patent:
5,738,872 →
Application:
08/742,166 →
Motif Libraries
Patent:
5,846,841 →
Application:
08/754,878 →
4-Aza Steroids
Patent:
6,365,597 →
Application:
08/798,258 →
Isatin Derivatives as Acetylcholinesterase Inhibitors and Analgesics
Patent:
6,100,276 →
Application:
08/806,012 →
3-Mercaptoacetylamino-1,5-Substituted-2-Oxo-Azepan Derivatives Useful as Inhibitors of Matrix Metalloproteinase
Patent:
6,953,788 →
Application:
08/893,080 →
Pharmaceutical Compositions for Piperidinalkanol Compounds
Patent:
5,855,912 →
Application:
08/943,460 →
Pharmaceutical Composition for Piperidinoalkanol Compounds
Patent:
5,932,247 →
Application:
08/948,005 →
Method for Producing Combinatorial Libraries Having a Predetermined Frequency of Each Species of Test Compound
Patent:
6,127,190 →
Application:
08/971,775 →
Novel Trans Cyclopentanyl Purine Analogs Useful as Immunosuppressants
Patent:
6,436,947 →
Application:
08/975,212 →
Use of (+)-a-(2,3-Dimethoxyphenyl-1-{2-(4-Fluorophenyl)Ethyl}-4- Piperidinemethanol in Treating Depressive Disorders and Bipolar Disorders
Patent:
6,022,877 →
Application:
09/026,323 →
Improved Assays for Beta-Amyloid Processing
Patent:
6,670,182 →
Application:
09/027,258 →
Three-Dimensional Array of Supports for Solid-Phase Parallel Synthesis and Method of Use
Pharmaceutical Composition for Combinaiton of Piperidinoalkanol-Decongestant
Patent:
6,039,974 →
Application:
09/127,478 →
Pharmaceutical Composition for Piperidinoalkanol Compounds
Patent:
6,113,942 →
Application:
09/157,841 →
1-Alkyl-,1-Alkenyl-,And 1-Alkynylaryl-2-Amino-1,3-Propanediols and Related Compounds
Patent:
6,500,849 →
Application:
09/237,689 →
4-Heteroaryl-1-Piperidinealkylamines and Derivatives Thereof and Their Therapeutic Utility
Patent:
37,729 →
Application:
09/240,842 →
6,9,-Disubstituted 2-[Trans-(4-Aminocyclohexyl) Amino] Purines
Patent:
6,413,974 →
Application:
09/247,052 →
6,9-Disubstituted 2-[Trans-(4-Aminocyclohexyl)Amino] Purines
Patent:
6,479,487 →
Application:
09/247,053 →
Profile Searching in Nucleic Acid Sequences Using the Fast Fourier Transformation
Patent:
6,287,773 →
Application:
09/314,534 →
Heterocycle Substituted Propenoic Acid Derivatives as Nmda Antagonist
Patent:
6,180,786 →
Application:
09/363,305 →
Use of R (+)-Alpha-(2,3-Dimethoxyphenyl)-1-[2-(4-Fluorophenyl) Ethyl]-4-Piperidinemethanol for the Treatment of Sleep Disorders
Patent:
6,277,864 →
Application:
09/382,932 →
Apparatus and Method for Synthesizing Combinational Libraries
Patent:
6,541,211 →
Application:
09/449,222 →
Biodegradable Polymer Encapsulated Pharmaceutical Compositions and Method for Preparing the Same
Patent:
6,455,526 →
Application:
09/454,555 →
Aminoalkylphenol Derivatives and Related Compounds
Patent:
6,479,495 →
Application:
09/459,046 →
Amidomalonamides Useful as Inhibitors of Mmp of Matrix Metalloproteinase
Patent:
6,329,550 →
Application:
09/464,907 →
Selective Inhibitors of Mmp-12
Patent:
6,352,976 →
Application:
09/464,908 →
1-Carboxymethyl-2-Oxo-Azepan Derivatives Useful as Selective Inhibitors of Mmp-12
Patent:
6,770,640 →
Application:
09/467,292 →
3-(Thio-Substitutedamido)-Lactams Useful as Inhibitors of Matrix Metalloproteinase
Patent:
6,262,080 →
Application:
09/467,304 →
Novel Substituted 4-(1H-Benzimidazol-2YL)[1,4]Diazepanes Useful for the Treatment of Allergic Disease
Patent:
6,194,406 →
Application:
09/513,847 →
Mathematical Analysis for the Estimation of Changes in the Level of Gene Expression
Patent:
6,502,039 →
Application:
09/577,634 →
Screening Methods for Altering Circadian Rhythms and for Human Casein Kinase I D and/or E Phosphorylation of Human Clock Proteins, Period 1, -2 and -3
Patent:
6,555,328 →
Application:
09/589,462 →
Novel Vectors for Improving Cloning and Expression in Low Copy Number Plasmids
Patent:
6,818,441 →
Application:
09/596,114 →
Sulfuric Acid Mono-[3({1-[2-(4-Fluoro-Phenyl)-Ethyl]-Piperidin -4-Yl}-Hydroxy-Methyl)-2-Methoxy-Phenyl]Ester
Patent:
6,465,490 →
Application:
09/615,246 →
Novel carboxy substituted acylic carboxamide derivatives
Patent:
6,316,445 →
Application:
09/648,005 →
Use of (+) -Alpha- (2, 3-Dimethoxyphenyl) - 1 - [ 2 - ( 4 - Fluorophenyl) Ethyl ] -4 - Piperidinemethanol in Treating Depressive Disorders and Bipolar Disorders
Patent:
6,380,216 →
Application:
09/699,647 →
Novel Elastase Inhibitors
Pseudopolymorph of ( - ) -Cis -2-(2 -Chlorophenyl) -5, 7-Dihydroxy-8 [4R- ( 3S-Hydroxy -1-Methyl)Piperidinyl ] -4H -1 -Benzopyran-4-One
Ethanol Solvate of (-)-Cis-2- (2-Chlorophenyl)-5, 7-Dihydroxy-8 [4R-(3S-Hydroxy-1-M Ethyl) Piperidinyl} -4H-1-Benzopyran-4-One
Spiro[Cyclopent[B]Indole-Piperidines]
3-Substituted Pyrrolidines Useful as Inhibitors of Matrix Metalloproteinases
The Use of R (+)-Alpha- (2,3-Dimethoxyphenyl) -1- [ 2- (4-Fluorophenyl) Ethyl] -4-Piper Idinemethanol for the Treatment of Sleep Disorders
Profile Searching in Nucleic Acid Sequences Using the Fast Fourier Transformation
Preserved Pharmaceutical Formulations
Patent:
7,109,161 →
Application:
10/031,922 →
Novel Processes for the Preparation or (R)-Alpha-(2,3-Dimethoxyphenyl)-1-[2-(4-Fluorophenyl)Ethyl]-4-Piperidinemethanol
Thienoisoxazolyl-And Thienylpyrrazolyl-Phenoxy Substituted Propyl Derivatives Useful as D4 Antagonists
Patent:
7,125,903 →
Application:
10/088,250 →
Thienoisoxazole Phenoxy Unsubstituted Ethyl and Propyl Derivatives Useful as D4 Antagonists
Patent:
7,091,199 →
Application:
10/088,369 →
Novel Antihistaminic Piperidine Derivatives and Intermediates for the Preparation Thereof
Novel Antihistaminic Piperidine Derivatives and Intermediates for the Preparation Thereof
Novel Antihistaminic Piperidine Derivatives and Intermediates for the Preparation Thereof
Novel Antihistaminic Piperidine Derivatives and Intermediates for the Preparation Thereof
Novel Antihistaminic Piperidine Derivatives and Intermediates for the Preparation Thereof
Processes for Preparing Anhydrous and Hydrate Forms of Antihistaminic Piperidine Derivatives, Polymorphs and Pseudomorphs Thereof
Processes for Preparing Anhydrous and Hydrate Forms of Antihistaminic Piperidine Derivatives, Polymorphs and Pseudomorphs Thereof
Novel Antihistaminic Piperidine Derivatives and Intermediates for the Preparation Thereof
6,9-Disubstituted 2-[Trans-(4-Aminocyclohexyl) Amino] Purines
Sulfuric Acid Mono-[ 3- ( {1- [ 2- (4-Fluoro-Phenyl ) -Ethyl ] -Piperidin-4-Yl} -Hydroxy-Methyl) -2-Methoxy-Phenyl ] Ester
Apparatus and Method for Synthesizing Combinatorial Libraries
Use of R (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of substance induced insomnia
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Sep 12, 2005
From: MERRELL DOW PHARMACEUTICALS INC.
To: MERRELL PHARMACEUTICALS INC.
Reel/Frame 016522/0001 →
Merger
May 18, 2006
From: MERRELL PHARMACEUTICALS INC.
To: AVENTIS INC.
Reel/Frame 017636/0297 →
Change of Name
Nov 29, 2007
From: HMR PHARMA INC.
To: AVENTIS HOLDINGS INC.
Reel/Frame 020174/0006 →
Assignment of Assignor's Interest
Mar 2, 2010
From: AVENTIS HOLDINGS INC.
To: AVENTISUB II INC.
Reel/Frame 024006/0487 →
Merger
Aug 19, 2014
From: AVENTISUB II INC.
To: AVENTIS HOLDINGS INC.
Reel/Frame 033566/0312 →
Merger
Aug 19, 2014
From: AVENTIS HOLDINGS INC.
To: AVENTISUB INC.
Reel/Frame 033566/0402 →
Assignment of Assignor's Interest
Aug 19, 2014
From: AVENTIS PHARMACEUTICALS INC.
To: HMR PHARMA INC.
Reel/Frame 033565/0920 →
Assignment of Assignor's Interest
Aug 19, 2014
From: HMR PHARMA, INC.
To: AVENTIS HOLDINGS INC.
Reel/Frame 033566/0043 →
Assignment of Assignor's Interest
Aug 19, 2014
From: AVENTIS HOLDINGS INC.
To: AVENTISUB II INC.
Reel/Frame 033566/0227 →
Assignment of Assignor's Interest
Aug 19, 2014
From: STRUPCZEWSKI, JOSEPH T.; HESLEY, GROVER C.; GLAMKOWSKI, EDWARD J.; CHIANG, YULIN
To: HOECHST-ROUSSEL PHARMACEUTICALS, INC.
Reel/Frame 033568/0253 →
Merger and Change of Name
Aug 19, 2014
From: HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED; HOECHST MARION ROUSSEL, INC.
To: HOECHST MARION ROUSSEL, INC.
Reel/Frame 033568/0457 →
Change of Name
Aug 19, 2014
From: HOECHST MARION ROUSSEL, INC.
To: AVENTIS PHARMACEUTICALS INC.
Reel/Frame 033568/0669 →
Change of Name
Aug 19, 2014
From: AVENTISUB INC.
To: AVENTISUB LLC.
Reel/Frame 033568/0749 →
Merger
Dec 9, 2014
From: AVENTISUB INC.
To: AVENTISUB II INC.
Reel/Frame 034566/0938 →
Merger
Dec 9, 2014
From: AVENTISUB II INC.
To: AVENTIS HOLDINGS INC.
Reel/Frame 034566/0931 →
Merger
Dec 9, 2014
From: AVENTIS PHARMACEUTICALS INC.
To: AVENTISUB LLC
Reel/Frame 034566/0958 →
Change of Name
Feb 3, 2015
From: AVENTISUB INC.
To: AVENTISUB LLC
Reel/Frame 034891/0100 →
Corrective Assignment to Correct the Name of the Assignor and the Name of Assignee Previously Recorded on Reel 034566 Frame 0938. Assignor(S) Hereby Confirms the the Correct Name of the Assignee Should Be Aventis Holdings Inc. and the Correct Name of the Assignee Should Be Aventisub Inc..
Feb 3, 2015
From: AVENTIS HOLDINGS INC.
To: AVENTISUB INC.
Reel/Frame 034891/0063 →